CARA
Cara Therapeutics Inc
Price:  
0.24 
USD
Volume:  
1,364,755.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA Relative Valuation

-10447.7%
Upside

As of 2024-06-19, the Relative Valuation of Cara Therapeutics Inc (CARA) is (25.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -10447.7%.

The range of the Relative Valuation is (24.78) - (14.83) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.9x - 9.1x 9.0x
Forward P/E multiples 15.2x - 28.4x 21.8x
Fair Price (24.78) - (14.83) (25.10)
Upside -10313.3% - -6214.6% -10447.7%
0.24 USD
Stock Price
(25.10) USD
Fair Price

CARA Relative Valuation - Historical P/E Data

Date P/E
2024-06-18 -0.15
2024-06-17 -0.16
2024-06-14 -0.21
2024-06-13 -0.27
2024-06-12 -0.42
2024-06-11 -0.41
2024-06-10 -0.41
2024-06-07 -0.38
2024-06-06 -0.39
2024-06-05 -0.43
2024-06-04 -0.41
2024-06-03 -0.42
2024-05-31 -0.40
2024-05-30 -0.37
2024-05-29 -0.38
2024-05-28 -0.41
2024-05-24 -0.41
2024-05-23 -0.45
2024-05-22 -0.47
2024-05-21 -0.46
2024-05-20 -0.46
2024-05-17 -0.46
2024-05-16 -0.49
2024-05-15 -0.47
2024-05-14 -0.44
2024-05-13 -0.46
2024-05-10 -0.44
2024-05-09 -0.47
2024-05-08 -0.45
2024-05-07 -0.49
2024-05-06 -0.48
2024-05-03 -0.48
2024-05-02 -0.47
2024-05-01 -0.47
2024-04-30 -0.46
2024-04-29 -0.46
2024-04-26 -0.42
2024-04-25 -0.43
2024-04-24 -0.41
2024-04-23 -0.43
2024-04-22 -0.45
2024-04-19 -0.41
2024-04-18 -0.42
2024-04-17 -0.45
2024-04-16 -0.43
2024-04-15 -0.44
2024-04-12 -0.47
2024-04-11 -0.50
2024-04-10 -0.50
2024-04-09 -0.51